MARVASO, GIULIA
MARVASO, GIULIA
Dipartimento di Oncologia ed Emato-Oncologia
Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis
2025 O. Mohamad, L. Mose, M. Ahmadsei, R. Kouzy, C. Zamboglou, L. Nicosia, F. Alongi, T. Zilli, S. Arcangeli, G. Marvaso, B.A. Jereczek-Fossa, M. Guckenberger, D.M. Aebersold, M. Shelan
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity
2025 M. Bilski, F. Mastroleo, L. Kuncman, P. Rogowski, S. Durante, C. Putzu, A. Chyrek, G. Marvaso, B. Fionda, L. Tagliaferii, J. Fijuth, A. Vavassori, R. Tolakanahalli, B.A. Jereczek-Fossa, R. Kotecha
Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee
2025 E. Forde, L. Van Den Berghe, M. Buijs, A. Cardone, J. Daly, P. Franco, N. Julka-Anderson, W. Lechner, L. Marignol, G. Marvaso, H. Nisbet, A. O'Donovan, N.S. Russell, P. Scherer
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025 G. Marvaso, G. Corrao, M. Zaffaroni, M.G. Vincini, C. Lorubbio, S. Gandini, C. Fodor, S. Netti, D. Zerini, S. Luzzago, F.A. Mistretta, K. Venetis, G. Cursano, T. Burla, K. Mazzocco, F. Cattani, G. Petralia, N. Fusco, G. Pravettoni, G. Musi, O. De Cobelli, C. Tang, P. Ost, D.A. Palma, R. Orecchia, B.A. Jereczek-Fossa
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in Italy
2025 A.E. Guerini, G. Marvaso, S. Tonoli, G. Corrao, M.A. Teriaca, M. Sepulcri, M. Scricciolo, A. Gava, S. Montrone, N. Giaj-Levra, B.N. Chiorda, G. Mantello, F. Fiorica, S. Borghesi, L. Belgioia, A. Caroli, A. Fiorentino, B.A. Jereczek-Fossa, S.M. Magrini, M. Buglione
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
2025 G. Francolini, N. Bertini, V. Di Cataldo, P. Garlatti, M. Aquilano, S. Caini, A. Bruni, G. Ingrosso, R.M. D'Angelillo, L. Tagliaferri, M. Augugliaro, L. Triggiani, S. Parisi, G. Timon, F. Arcidiacono, G. Marvaso, B.A. Jereczek-Fossa, A. Lancia, C. Franzese, F. Alongi, G. Simontacchi, D. Greto, P. Bonomo, M. Loi, G. Frosini, L. Burchini, I. Desideri, I. Meattini, R.K. Valicenti, L. Livi
Stereotactic body radiotherapy combined with immunotherapy or targeted therapy: a screenshot from Italy on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
2025 G. Corrao, G. Marvaso, M. Zaffaroni, M.G. Vincini, S. Badellino, P. Borghetti, F. Cuccia, M. Federico, G. Montesi, A. Pontoriero, C. Franzese, M. Loi, B.A. Jereczek-Fossa, M. Scorsetti
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis
2025 M. Miszczyk, M. Bilski, T. Koi, K. Konat-Baska, A. Suleja, T. Fazekas, A. Matsukawa, I. Tsuboi, R. Schulz, P. Rajwa, E. Laukhtina, M.R. Hassler, G. Marvaso, P. Sargos, P. Ost, G. Ploussard, B. Jereczek-Fossa, M. Roupret, P. Chlosta, P.I. Karakiewicz, M. Babjuk, J.Y.-. Teoh, M. Moschini, P. Gontero, S.F. Shariat
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
2025 V. Murthy, G. Marvaso, B.A. Jereczek-Fossa, S.A. Thoma, M. Vogel, N.-. Schmidt-Hegemann, M. Shelan, S. Siva, T. Hoelscher, A.U. Kishan, J.C. Peeken, S. Gillessen, M. Guckenberger, K. Herrmann, W.P. Fendler, T. Zilli, S.K.B. Spohn, C. Zamboglou
Precision Radiotherapy for Kidney Cancer: A Rising Ally in Multidisciplinary Care
2025 B.A. Jereczek-Fossa, F. Mastroleo, G. Marvaso
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study
2025 F. Mastroleo, R. Villa, M. Zaffaroni, M.G. Vincini, C. Franzese, L. Nicosia, F. Matrone, A. Donofrio, A. Magli, L. Triggiani, S. Barra, G. Timon, M. Augugliaro, V. Burgio, G. Francolini, M. Hasterok, M. Miszczyk, N. Simoni, C. Spatola, F. Alongi, S. Arcangeli, M. Scorsetti, G. Marvaso, B.A. Jereczek-Fossa
Understanding the role of nerves in head and neck cancers - a review
2025 K. Rutkowski, M. Gola, J. Godlewski, A. Starzynska, G. Marvaso, F. Mastroleo, M. Giulia Vincini, A. Porazzi, M. Zaffaroni, B.A. Jereczek-Fossa
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia
2025 T. Burla, M. Zaffaroni, G. Marvaso, K. Mazzocco, G. Galli, M.G. Vincini, F. Mastroleo, M. Sarra Fiore, G. Pravettoni, B.A. Jereczek-Fossa
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes
2025 C. Vaccaro, F.A. Mistretta, M.L. Piccinelli, E. Lievore, L.M.I. Jannello, M. Fontana, M. Tozzi, P. Della Vigna, G. Bonomo, G. Varano, F. Mastroleo, G. Marvaso, B.A. Jereczek-Fossa, S. Luzzago, F. Orsi, G. Musi
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis
2024 G. Corrao, G. Marvaso, F. Mastroleo, A. Biffi, G. Pellegrini, S. Minari, M.G. Vincini, M. Zaffaroni, D. Zerini, S. Volpe, S. Gaito, G.C. Mazzola, L. Bergamaschi, F. Cattani, G. Petralia, G. Musi, F. Ceci, O. De Cobelli, R. Orecchia, D. Alterio, B.A. Jereczek-Fossa
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?
2024 G. Marvaso, A. Vitullo, G. Corrao, M.G. Vincini, M. Zaffaroni, R. Villa, F. Mastroleo, L. Kuncman, D. Zerini, I. Repetti, C. Lorubbio, G. Musi, O. De Cobelli, B.A. Jereczek-Fossa
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
2024 F. Cuccia, C. Franzese, S. Badellino, P. Borghetti, M. Federico, G. Marvaso, G. Montesi, A. Pontoriero, G. Ferrera, F. Alongi, M. Scorsetti
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperativane Surgical Margins: A Clinical Trial Protocol
2024 G. Musi, F.A. Mistretta, O. de Cobelli, A. Bellin, G.G. Vago, G. Pravettoni, D. Bottero, M.L. Piccinelli, M. Ferro, M. Ivanova, G. Petralia, G. Marvaso, B.A. Jereczek-Fossa, V. Bagnardi, G. Renne, N. Fusco, S. Luzzago
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
2024 S. Natangelo, D. Trapani, C. Koukoutzeli, L. Boscolo Bielo, G. Marvaso, B.A. Jereczek-Fossa, G. Curigliano
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
2024 G. Marvaso, B.A. Jereczek-Fossa, M. Zaffaroni, M.G. Vincini, G. Corrao, N. Andratschke, E.H. Balagamwala, J. Bedke, O. Blanck, U. Capitanio, R.J.M. Correa, G. De Meerleer, C. Franzese, A. Gaeta, S. Gandini, C. Garibaldi, P.C. Gerszten, S. Gillessen, W.R. Grubb, M. Guckenberger, R. Hannan, P.M. Jhaveri, M. Josipovic, L.G.W. Kerkmeijer, E.J. Lehrer, M. Lindskog, A.V. Louie, Q. Nguyen, P. Ost, D.A. Palma, G. Procopio, M. Rossi, M. Staehler, A.C. Tree, Y.M. Tsang, N. Van As, N.G. Zaorsky, T. Zilli, D. Pasquier, S. Siva